These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

36 related articles for article (PubMed ID: 2561637)

  • 1. A heparin which binds to the envelope glycoprotein gp120 inhibits human immunodeficiency virus replication.
    Cardin AD; Taylor DL; Krstenansky JL; Tyms AS; Jackson RL
    Trans Assoc Am Physicians; 1989; 102():101-9. PubMed ID: 2561637
    [No Abstract]   [Full Text] [Related]  

  • 2. An anti-human immunodeficiency virus multiple antigen peptide encompassing the cleavage region of the env precursor interferes with membrane fusion at a post-CD4 binding step.
    Barbouche R; Decroly E; Kieny MP; Fenouillet E
    Virology; 2000 Jul; 273(1):169-77. PubMed ID: 10891419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for the cooperation of gp120 amino acids 322 and 448 in SIVmac entry.
    Morrison HG; Kirchhoff F; Desrosiers RC
    Virology; 1993 Jul; 195(1):167-74. PubMed ID: 8317093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutant CD4 molecules with improved binding to HIV envelope protein gp120 selected by phage display.
    Krykbaev R; McKeating J; Jones I
    Virology; 1997 Aug; 234(2):196-202. PubMed ID: 9268150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent inhibition of HIV-1 fusion by cyanovirin-N requires only a single high affinity carbohydrate binding site: characterization of low affinity carbohydrate binding site knockout mutants.
    Chang LC; Bewley CA
    J Mol Biol; 2002 Apr; 318(1):1-8. PubMed ID: 12054763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of an anti-HIV peptide, T22, with gp120 and CD4.
    Tamamura H; Otaka A; Murakami T; Ishihara T; Ibuka T; Waki M; Matsumoto A; Yamamoto N; Fujii N
    Biochem Biophys Res Commun; 1996 Feb; 219(2):555-9. PubMed ID: 8605026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycans and proteoglycans are involved in the interactions of human immunodeficiency virus type 1 envelope glycoprotein and of SDF-1alpha with membrane ligands of CD4(+) CXCR4(+) cells.
    Mbemba E; Benjouad A; Saffar L; Gattegno L
    Virology; 1999 Dec; 265(2):354-64. PubMed ID: 10600606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is the V3 loop involved in HIV binding to CD4?
    Dettin M; Ferranti P; Scarinci C; Picariello G; Di Bello C
    Biochemistry; 2003 Aug; 42(30):9007-12. PubMed ID: 12885233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic CD4 exocyclics inhibit binding of human immunodeficiency virus type 1 envelope to CD4 and virus replication in T lymphocytes.
    Zhang X; Gaubin M; Briant L; Srikantan V; Murali R; Saragovi U; Weiner D; Devaux C; Autiero M; Piatier-Tonneau D; Greene MI
    Nat Biotechnol; 1997 Feb; 15(2):150-4. PubMed ID: 9035140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Actinohivin, a novel anti-human immunodeficiency virus protein from an actinomycete, inhibits viral entry to cells by binding high-mannose type sugar chains of gp120.
    Chiba H; Inokoshi J; Nakashima H; Omura S; Tanaka H
    Biochem Biophys Res Commun; 2004 Mar; 316(1):203-10. PubMed ID: 15003531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformational changes of gp120 in epitopes near the CCR5 binding site are induced by CD4 and a CD4 miniprotein mimetic.
    Zhang W; Canziani G; Plugariu C; Wyatt R; Sodroski J; Sweet R; Kwong P; Hendrickson W; Chaiken I
    Biochemistry; 1999 Jul; 38(29):9405-16. PubMed ID: 10413516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional analysis of the disulfide-bonded loop/chain reversal region of human immunodeficiency virus type 1 gp41 reveals a critical role in gp120-gp41 association.
    Maerz AL; Drummer HE; Wilson KA; Poumbourios P
    J Virol; 2001 Jul; 75(14):6635-44. PubMed ID: 11413331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular biology of HIV: new insights into the virus life-cycle.
    Cann AJ; Karn J
    AIDS; 1989; 3 Suppl 1():S19-34. PubMed ID: 2558687
    [No Abstract]   [Full Text] [Related]  

  • 14. Structural requirements for and consequences of an antiviral porphyrin binding to the V3 loop of the human immunodeficiency virus (HIV-1) envelope glycoprotein gp120.
    Neurath AR; Strick N; Debnath AK
    J Mol Recognit; 1995; 8(6):345-57. PubMed ID: 9052975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of chronic alcohol drinking on receptor-binding, internalization, and degradation of human immunodeficiency virus 1 envelope protein gp120 in hepatocytes.
    Singh AK; Jiang Y; Gupta S
    Alcohol; 2007 Dec; 41(8):591-606. PubMed ID: 17980997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of mutations in constant regions 3 and 4 of envelope of simian immunodeficiency virus.
    Morrison HG; Kirchhoff F; Desrosiers RC
    Virology; 1995 Jul; 210(2):448-55. PubMed ID: 7618279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural requirements of glycosaminoglycans for their interaction with HIV-1 envelope glycoprotein gp120.
    Matos PM; Andreu D; Santos NC; Gutiérrez-Gallego R
    Arch Virol; 2014 Mar; 159(3):555-60. PubMed ID: 24046088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthetic protein binds AIDS virus and prevents its spread.
    N Y State J Med; 1990 Sep; 90(9):480. PubMed ID: 2293128
    [No Abstract]   [Full Text] [Related]  

  • 19. Anti-HIV drug mechanism.
    Jones IM; Jacob GS
    Nature; 1991 Jul; 352(6332):198. PubMed ID: 1857411
    [No Abstract]   [Full Text] [Related]  

  • 20. Removing human immunodeficiency virus (HIV) from human blood using immobilized heparin.
    Nassar RA; Browne EP; Chen J; Klibanov AM
    Biotechnol Lett; 2012 May; 34(5):853-6. PubMed ID: 22207147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.